John Johnson - Chief Executive Officer, Melinta Therapeutics, Inc

As of July 2, 2019


John Johnson Net Worth

  • Net worth is estimated to be at least $1.61M
  • Owns at least 37,400 units of Melinta Therapeutics, Inc stock
  • Sold an estimated value of $72.44K in the last year at Melinta Therapeutics, Inc

John Johnson Trading

  • Largest sale of shares was 13,000 units , worth over $72.44K on July 2, 2019
  • In total has made about 5 transactions over a year
  • Usually trades in June, with the busiest year in 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

John Johnson Mailing Address

  • Mailing address is Dendreon Corporation 1301 2nd Avenue Seattle WA 98101 WA

Melinta Therapeutics, Inc Insider Trading

  • The most recent transaction was 13,000 units sold on July 2, 2019 by John Johnson worth over $72.44K
  • In the last year, insiders at Melinta Therapeutics, Inc sold an estimated value of $72.44K and bought an estimated value of $194.86M
  • The most active traders are John Johnson, Chief Executive Officer,  Kevin Ferro, Director,  and David Gill, Director
  • Insider trading is most common in June, with the busiest year in 2018

MELINTA THERAPEUTICS, INC. /NEW/ Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1